162 related articles for article (PubMed ID: 12453881)
1. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.
Borson ND; Lacy MQ; Wettstein PJ
Blood; 2002 Dec; 100(13):4629-39. PubMed ID: 12453881
[TBL] [Abstract][Full Text] [Related]
2. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
3. Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma.
Borson ND; Lacy MQ; Wettstein PJ
Mamm Genome; 2006 Mar; 17(3):248-56. PubMed ID: 16518692
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of Pax-5 gene in human myeloma cells.
Mahmoud MS; Huang N; Nobuyoshi M; Lisukov IA; Tanaka H; Kawano MM
Blood; 1996 May; 87(10):4311-5. PubMed ID: 8639790
[TBL] [Abstract][Full Text] [Related]
5. Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray.
Lin P; Mahdavy M; Zhan F; Zhang HZ; Katz RL; Shaughnessy JD
Mod Pathol; 2004 Oct; 17(10):1217-22. PubMed ID: 15195108
[TBL] [Abstract][Full Text] [Related]
6. Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells.
Nagy M; Chapuis B; Matthes T
Br J Haematol; 2002 Feb; 116(2):429-35. PubMed ID: 11841448
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the B lymphocyte-induced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter.
Tunyaplin C; Shapiro MA; Calame KL
Nucleic Acids Res; 2000 Dec; 28(24):4846-55. PubMed ID: 11121475
[TBL] [Abstract][Full Text] [Related]
8. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
[TBL] [Abstract][Full Text] [Related]
9. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.
Lin KI; Angelin-Duclos C; Kuo TC; Calame K
Mol Cell Biol; 2002 Jul; 22(13):4771-80. PubMed ID: 12052884
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
12. The expression of PRDI-BF1 beta isoform in multiple myeloma plasma cells.
Ocaña E; González-García I; Gutiérrez NC; Mora-López F; Brieva JA; Campos-Caro A
Haematologica; 2006 Nov; 91(11):1579-80. PubMed ID: 17043021
[TBL] [Abstract][Full Text] [Related]
13. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.
Lin FR; Kuo HK; Ying HY; Yang FH; Lin KI
Cancer Res; 2007 Dec; 67(24):11914-23. PubMed ID: 18089822
[TBL] [Abstract][Full Text] [Related]
15. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines.
Ferrer M; López-Borges S; Lazo PA
Oncogene; 1999 Apr; 18(13):2253-9. PubMed ID: 10327071
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype.
Usui T; Wakatsuki Y; Matsunaga Y; Kaneko S; Koseki H; Kita T
J Immunol; 1997 Apr; 158(7):3197-204. PubMed ID: 9120274
[TBL] [Abstract][Full Text] [Related]
17. Loss of Pax5 promotes plasma cell differentiation.
Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
[TBL] [Abstract][Full Text] [Related]
18. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
19. Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene.
Fairfax KA; Corcoran LM; Pridans C; Huntington ND; Kallies A; Nutt SL; Tarlinton DM
J Immunol; 2007 Apr; 178(7):4104-11. PubMed ID: 17371965
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of PAX5 induces apoptosis in multiple myeloma cells.
Proulx M; Cayer MP; Drouin M; Laroche A; Jung D
Int J Hematol; 2010 Oct; 92(3):451-62. PubMed ID: 20882442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
